Korea’s pharmaceutical technology transfer fees top 2.5 trillion won in 22 years
Published: 2012-06-01 06:57:00
Updated: 2012-06-01 06:57:00
The country saw a drug-related cumulative technology transfer fee of 2.5 trillion won ($2.3 billion) over the past 22 years since Hanmi Pharma exported its formulation technology of ceftriaxone to Switzerland based Roche in 1989, the Korea Drug Research Association said Wednesday.
The associat...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
